Thu.Jan 13, 2022

article thumbnail

5 questions facing gene therapy in 2022

Bio Pharma Dive

As record levels of money pour into gene therapy research, biotechs are under increased pressure to address issues related to safety, delivery and overlapping pipelines.

article thumbnail

Pharma spent $3.9B on TV ads in 2021

World of DTC Marketing

(Endpoints) Pharma TV advertising boomed in 2021 – to the tune of $3.91 billion across prescription meds, iSpot reports. That’s an increase of 4.8% year over year, which may not sound like much but marks pharma’s steady growth through the pandemic. And its continued growth of national TV ad spending while the rest of the industry is on the decline in the US.

Branding 217
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

New study finds AstraZeneca booster generates higher antibodies against Omicron

Pharma Times

AstraZeneca (AZ) has reported preliminary data from a trial it conducted on its COVID-19 booster shot, Vaxzevria.

Antibody 172
article thumbnail

Korea’s Samsung Bio reveals massive capacity boost on the cards

BioPharma Reporter

Samsung Biologics flags further facility construction plans, with biologics, cell and gene therapies and next-generation vaccines to be the focus of those new sites.

article thumbnail

The New Age of Decentralized Clinical Trials

White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations

article thumbnail

Supply chain middlemen ‘pocket half of US branded medicine spending’

pharmaphorum

In 2020, over half of total spending on brand medicines went to the supply chain, middlemen and other stakeholders, overtaking the amount going to drug manufacturers for the first time, according to a new study. The report from Berkeley Research Group (BRG) – which was funded by the pharma industry trade group PhRMA – reveals a steady decrease in the proportion received by drugmakers from around 67% in 2013 to 49.5% in 2020.

Branding 111
article thumbnail

Protagen, BioAnalytix, and GeneWerk unveil combined CRO business: ProtaGene

BioPharma Reporter

Protagen, BioAnalytix, and GeneWerk this week announced their unified operations and re-brand as ProtaGene, a CRO partner for the biologics and cell and gene therapy developers, from discovery to commercialization.

More Trending

article thumbnail

Third dose of AZ’s COVID jab boosts Omicron antibodies

pharmaphorum

Preliminary data from an ongoing trial of AstraZeneca’s COVID-19 vaccine Vaxzevria has shown that a booster dose stimulates an increase in antibodies against Omicron, as well as other variants of the virus, including Alpha, Beta, Delta, and Gamma. The increased immune response was seen in people who received AZ’s shot as their primary vaccination as well as mRNA vaccines, said the drugmaker, which said the data “add to the growing body of evidence supporting Vaxzevria as a thir

article thumbnail

Xtalks Voices with Food Industry Training Expert Kristin Kastrup from Intertek Alchemy

XTalks

In this video, Xtalks spoke with Kristin Kastrup, a Senior Consultant for HR and Training Optimization at Intertek Alchemy, about training technology for frontline workers in the food industry. Xtalks talked with Kristin about her role at Intertek Alchemy and why companies in the food industry may be having challenges hiring and retaining their workforces.

article thumbnail

Sanofi places $75m bet with ABL on popular Parkinson’s drug target

pharmaphorum

Sanofi has joined a growing list of drugmakers going after alpha-synuclein targeting drugs for Parkinson’s disease, licensing a bispecific antibody from South Korea’s ABL Bio in a deal that could be worth more than $1 billion. The French pharma group is paying $75 million upfront for the preclinical-stage drug, codenamed ABL301, a double-headed antibody that targets alpha-synuclein at one end and the IGF-1 receptor at the other, a mechanism designed to make it cross the blood-brain b

article thumbnail

Chobani Releases Plant-Based Coffee Creamers as IPO Nears

XTalks

Yogurt maker Chobani is launching a line of plant-based coffee creamers, which will join the company’s robust line of dairy-free and oat-based options. The new creamers are made with cane sugar, sunflower oil and medium-chain triglycerides oil from coconut and come in a variety of flavors including caramel macchiato, chocolate hazelnut, french vanilla and sweet and creamy.

article thumbnail

Roles and Responsibilities of Specialized Clinical Supply Experts

When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.

article thumbnail

More than ever expected of today’s data managers: IQVIA

Outsourcing Pharma

With the amount of available data increasing and technology evolving, says a company leader, the job of data manager is more demanding than ever before.

article thumbnail

BioNTech, InstaDeep showcase early warning system for COVID variants

pharmaphorum

BioNTech and artificial intelligence start-up InstaDeep say they have developed an early warning system that can predict high-risk variants of COVID-19 from their genetic sequences much earlier than with current methods. In testing, the AI was able to correctly identify more than 90% of variants of concern – including the Omicron strain currently spreading around the globe – around two months ahead of their designation by the World Health Organization (WHO).

article thumbnail

Study finds hydroxychloroquine delays disability for least treatable form of multiple sclerosis

Scienmag

A University of Calgary study has found promising results for the generic drug hydroxychloroquine when used to treat the evolution of disability of primary progressive multiple sclerosis (MS), the least treatable form of the autoimmune disease. MS affects about 90,000 Canadians with about 15 per cent of those diagnosed with primary progressive MS, one of the […].

article thumbnail

Collaborative research approach set to accelerate treatment of Alport syndrome

Pharma Times

Despite diagnosis and treatment options improving for the rare kidney condition, further action is urgently required.

Research 106
article thumbnail

The New Age of Decentralized Clinical Trials

This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.

article thumbnail

Heart disease causes early brain dysfunction and can treble key Alzheimer’s protein

Scienmag

• Scientists have discovered that heart disease causes brain dysfunction that could lead to dementia before the buildup of plaque in blood vessels of the brain • Heart disease causes problems in the brain that causes less blood to reach the neurons that need it • Findings also show that a combination of heart […].

Protein 88
article thumbnail

US Supreme Court blocks Biden’s broad vaccine mandate in 6-3 decision

pharmaphorum

The US Supreme Court handed down two decisions today relating to COVID-19 vaccine mandates, issuing a stay to prevent a broad mandate from the Occupational Health and Safety Administration, but allowing a more limited Centers for Medicare and Medicaid Services mandate relating to healthcare workers. The OSHA mandate , due to kick in this week, would have required either vaccinations or masking and regular testing for US employers with 100 or more employees, with some carve-out exceptions for out

article thumbnail

What we do and don’t know about the many ways COVID-19 can impact pregnant women and their babies

Scienmag

Pregnant women should get vaccinated to minimize the detrimental health effects COVID-19 has on the placenta, the fetus and the newborn, states Roberta L. DeBiasi, M.D., M.S., division chief of Pediatric Infectious Diseases at Children’s National Hospital in an editorial published in The Journal of Infectious Diseases. The editorial provides a comprehensive review of what […].

article thumbnail

San Diego cell therapy CDMO acquired by Great Point Partners

BioPharma Reporter

Performance Cell Manufacturing, a CDMO with a focus on manufacturing cell therapies, has been acquired by Great Point Partners and will now operate under the name Cellipont Bioservices.

article thumbnail

Accelerating Clinical Supply Through Integrated Drug Development

As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.

article thumbnail

First melanoma test to offer reassurance of low risk of cancer spread

Scienmag

A pioneering test which reliably predicts the spread or return of the most deadly form of skin cancer has been developed by a team of Newcastle scientists and clinicians. Credit: AMLo Biosciences & Newcastle University A pioneering test which reliably predicts the spread or return of the most deadly form of skin cancer has been […].

article thumbnail

AZ, Scorpion strike deal on elusive transcription factor targets in cancer

pharmaphorum

AstraZeneca has expanded its efforts to develop new therapies targeting transcription factors – proteins that regulate processes in the cell that have become a hot topic for drug discovery in cancer and other diseases. The UK-headquartered pharma is buying into a drug discovery platform developed by Boston, US biotech Scorpion Therapeutics, paying $75 million upfront to get the ball rolling on the partnership, with undisclosed option fees and milestone payments also on offer.

Protein 59
article thumbnail

Kessler Foundation awarded federal grant to study virtual reality immersive technology for visual neglect in traumatic brain injury

Scienmag

East Hanover, NJ – January 13, 2022 – Peii (Peggy) Chen, PhD, senior research scientist in the Center for Stroke Rehabilitation Research at Kessler Foundation, has been awarded a $376,109 grant from the U.S. Department of Defense, U.S. Army Medical Research & Development Command, Congressionally Directed Medical Research Programs (CDMRP), Vision Research Program.

article thumbnail

Starting as a Medical Assistant

ECRG Media's Clinical Research Podcast

Don't forget to Subscribe for new content! Merch: [link] Subscribe: [link] Email: eliteclinicalgroup@gmail.com Podcast: [link] Steemit: [link] Advertise: eliteclinicalgroup@gmail.com Watch: » Industry News: [link] » All Videos: [link] » Interview Recaps: [link] » Glassdoor Reviews: [link] We do: » Insider Interviews » Resume Reviews » Question and Answer » Discuss all things Clinical Research » News and Product Reviews » Education Elite Clinical Research Group or ECRG for short is a content crea

article thumbnail

How Machine Learning Drives Clinical Trial Efficiency

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

article thumbnail

Swapping just one food item per day can make diets substantially more planet-friendly

Scienmag

If your New Year’s resolution is to eat better for the planet, a new Tulane University study finds it may be easier than you think. Credit: Tulane University If your New Year’s resolution is to eat better for the planet, a new Tulane University study finds it may be easier than you think. Americans who […].

87
article thumbnail

Starting as a Medical Assistant

ECRG Media's Clinical Research Podcast

Don't forget to Subscribe for new content! Merch: [link] Subscribe: [link] Email: eliteclinicalgroup@gmail.com Podcast: [link] Steemit: [link] Advertise: eliteclinicalgroup@gmail.com Watch: » Industry News: [link] » All Videos: [link] » Interview Recaps: [link] » Glassdoor Reviews: [link] We do: » Insider Interviews » Resume Reviews » Question and Answer » Discuss all things Clinical Research » News and Product Reviews » Education.

article thumbnail

Unusual team finds gigantic planet hidden in plain sight

Scienmag

A UC Riverside astronomer and a group of eagle-eyed citizen scientists have discovered a giant gas planet hidden from view by typical stargazing tools. Credit: Laurie Hatch/Lick Observatory A UC Riverside astronomer and a group of eagle-eyed citizen scientists have discovered a giant gas planet hidden from view by typical stargazing tools. The planet, TOI-2180 […].

article thumbnail

Inauguration of Pharmacy Council of India: First step in Implementation of Pharmacy Act, 1948

Pharma Tutor

Inauguration of Pharmacy Council of India: First step in Implementation of Pharmacy Act, 1948. About Authors. Dr. R. S. Thakur. Chief Editor, Journal of Pharmaceutical Research. Krupanidhi College of Pharmacy, Bengaluru-560035. Email: drramsthakur@gmail.com. admin. Thu, 01/13/2022 - 17:31. Tags. Articles.

article thumbnail

The New Clinical Trial Supply Chain: Resilient, Flexible, and Patient-Centric

The global landscape of clinical trials is rapidly changing as studies become more complex. An increasing number of sponsors are seeking enhanced flexibility in their supply chains to address a variety of clinical supply challenges, including patient demand and reducing delays. Demand-led supply and direct-to-patient distribution are next-generation solutions that are helping to meet these growing needs, allowing for more streamlined processes and patient-centric studies.

article thumbnail

Gabriela Meléndez-Peláez to receive 2022 Penn Nursing Renfield Foundation Award for Global Women’s Health

Scienmag

PHILADELPHIA, PA (January 13, 2022) – Gabriela Meléndez-Peláez, a Guatemalan nurse-midwife, maternal health advocate, and the Founder of Asociación Corazón del Agua, will receive the 2022 Penn Nursing Renfield Foundation Award for Global Women’s Health for her tireless work in addressing maternal health inequities in Guatemala. The award ceremony will be held virtually on March […].

Nurses 85
article thumbnail

2022 Pharma Marketing Trend to Watch: Digital Medicine

Intouch Solutions

At the crossroads of computer technology and drug development, digital therapeutics have become a fully-fledged part of healthcare and a full competitor to traditional medications. As the industry organization Digital Medicine Society defines it, digital medicine is the use of technology for measurement and intervention in service of human health. This can include the use of wearables in clinical trials, or as therapy alternatives or adjuncts.

article thumbnail

Novel treatment target for heart disease found in the blood vessel wall

Scienmag

AUGUSTA, Ga. (Jan. 14, 2022) – A molecule of RNA called CARMN has been found in abundance in the healthy smooth muscle cells that help give our blood vessels strength and flexibility, and distinctly decreased in vascular diseases like atherosclerosis, a major cause of heart attack and stroke, scientists report. Credit: Michael Holahan, Augusta University AUGUSTA, […].

RNA 83
article thumbnail

CMS decision to restrict Aduhelm coverage could have ‘ripple effect’ on other potential therapies

BioPharma Reporter

This week the US Centers for Medicare & Medicaid Services (CMS) has announced a long-awaited proposal for Aduhelm coverage: proposing it would only cover the recently approved Alzheimerâs Drug for people in qualifying clinical trials. This could have a ripple effect on decisions from private insurers and other potential drugs in the pipeline.

article thumbnail

Deliver Fast, Flexible Clinical Trial Insights with Spotfire

Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.